Search

Author/Creator Adamson, C

1. Alkaline phosphatase and bilirubin combined are a powerful predictor of outcome in patients with heart failure and reduced ejection fraction: an analysis of the ATMOSPHERE and PARADIGM-HF trials. (3rd October 2022)

Authors:
Adamson, C; Butt, J H; Rouleau, J; Abraham, W; Desai, A; Dickstein, K; Kober, L; Lefkowitz, M P; Packer, M; Petrie, M C; Swedberg, K; Solomon, S D; Zile, M; Jhund, P S; McMurray, J J V
Journal:
European heart journal
Issue:
Volume 43(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Elevated markers of liver function are associated with poorer outcomes in HFREF: an analysis of DAPA-HF. (14th October 2021)

Authors:
Cowan, L; Adamson, C; Docherty, K; Inzucchi, S; Koeber, L; Kosiborod, M; Martinez, F; Ponikowski, P; Sabatine, M; Solomon, S; Bengtsson, O; Sjostrand, M; Langkilde, A; Jhund, P; McMurray, J
Journal:
European heart journal
Issue:
Volume 42(2021)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Outcomes related to IGFBP-7 in patients with heart failure and reduced ejection fraction and effects of dapagliflozin: findings from DAPA-HF. (3rd October 2022)

Authors:
Adamson, C; Welsh, P; Morrow, D A; Docherty, K F; Hammarstedt, A; Inzucchi, S E; Kober, L; Kosiborod, M N; Martinez, F A; Ponikowski, P; Sabatine, M S; Solomon, S D; Sattar, N; Jhund, P S; McMurray, J J V
Journal:
European heart journal
Issue:
Volume 43(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗